RobertB.JaffeMD
Obstetrics & Gynecology • San Francisco, CAReproductive Endocrinology & Infertility
Professor, Obstetrics/Gynecology & Reproductive Science, UCSF School of Medicine
Are you Dr. Jaffe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 19 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2356 Sutter St
San Francisco, CA 94115Phone+1 415-476-6130Fax+1 415-476-0793- Is this information wrong?
Summary
- Dr. Robert Jaffe, MD is an obstetrician/gynecologist in San Francisco, California. He is currently licensed to practice medicine in California. He is a Professor at UCSF School of Medicine.
Education & Training
University of ColoradoResidency, Obstetrics and Gynecology, 1959 - 1963- University of ColoradoResidency, Internal Medicine, 1958 - 1959
- University of Colorado School of MedicineInternship, Transitional Year, 1957 - 1958
University of Michigan Medical SchoolClass of 1957
Certifications & Licensure
CA State Medical License Active through 2014- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1985
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss Start of enrollment: 2002 May 01
Publications & Presentations
PubMed
- 35 citationsDll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor GrowthJie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton, Xiao Yun Yang, Yunjie Sun, Michael McGuire, Rajesha Rupaimoole, Archana S. Nagaraja, Yu Kang, Tao Li...> ;Molecular Cancer Therapeutics. 2016 Jun 1
- Infiltrative neurosarcoidosis presenting as secondary amenorrhea: case report and review of the literature.Lusine Aghajanova, Robert B. Jaffe, Christopher N. Herndon> ;Obstetrical & Gynecological Survey. 2013 Jun 1
- 60 citationsPhase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L. Coleman, Linda R. Duska, John V. Heymach, Aparna A. Kamat, Susan C. Modesitt, Kathleen M. Schmeler, Revathy B. Iyer, Michael E. Garcia, Debbie L Miller, Edwa...> ;The Lancet. Oncology. 2011 Nov 1
- Join now to see all
Press Mentions
- Profiles in Ob/Gyn: A Pioneer in Preeclampsia ResearchApril 23rd, 2019
Celmatix Launches MyFertility Compass™ to Give Women Better Insights into Their Family Building JourneyJuly 10th, 2018
Prominent Physicians Join Juniper Pharmaceuticals' Scientific Advisory BoardJanuary 20th, 2016- Join now to see all
